Trial intelligence / Profile preview

10 vs 20 mL Bupivacaine for Popliteal Plexus Block in Total Knee Arthroplasty

2024-520204-26-00Phase 4Completed

Sponsor
Central Denmark Region
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Central Denmark Region. Primary endpoint: Total opioid consumption 0–24 hours. Started Mar 2025; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2024-520204-26-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-520204-26-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call